You can find the annual or quarterly income statement of Mainz Biomed NV here for insights into the performance and operational efficiency of Mainz Biomed NV.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022H2

FY2022H1

Total revenue

--373.22K

--520.77K

--214.76K

--181.67K

--248.94K

--250.10K

--290.07K

--239.81K

Revenue

--373.22K

--520.77K

--214.76K

--181.67K

--248.94K

--250.10K

--290.07K

--239.81K

Cost of revenue

--117.37K

--201.74K

--80.03K

--94.48K

--100.15K

--111.16K

--228.72K

--119.00K

Operating expenses

--8.98M

--10.33M

--6.81M

--5.82M

--8.18M

--6.74M

--14.15M

--12.75M

R&D expenses

--2.24M

--2.96M

--1.82M

--1.72M

--3.42M

--2.47M

--4.03M

--886.36K

Depreciation, depletion, and amortization

--554.24K

--453.42K

--204.47K

--279.58K

--304.80K

--287.35K

--317.43K

--62.37K

Other operating expenses

----

---69.11K

Operating profit

---8.61M

---9.81M

---6.59M

---5.64M

---7.93M

---6.49M

---13.86M

---12.51M

Net non-operating interest income (expenses)

Non-operating interest expense

--411.77K

--655.59K

--565.59K

--48.52K

--49.83K

--42.75K

--173.41K

--75.22K

Gains from sale of securities

---3.99K

---3.88K

---243.99K

--46.58K

--46.36K

--39.41K

----

---40.70K

Special income (expenses)

---1.82M

---482.20K

--709.68K

---29.25K

--0.00

--35.85K

----

Other non-operating income (expenses)

--218.41K

---74.76K

--1.51M

---627.93K

---322.18K

---105.87K

--253.10K

--23.82K

Income before tax

---10.63M

---11.02M

---5.18M

---6.30M

---8.25M

---6.56M

---13.78M

---12.60M

Income after tax

---10.63M

---11.02M

---5.18M

---6.30M

---8.25M

---6.56M

---13.78M

---12.60M

Net income from continuous operations

---10.63M

---11.02M

---5.18M

---6.30M

---8.25M

---6.56M

---13.78M

---12.60M

Net income attributable to controlling interests

---10.63M

---11.02M

---5.18M

---6.30M

---8.25M

---6.56M

---13.78M

---12.60M

Net income attributable to common shareholders

---10.63M

---11.02M

---5.18M

---6.30M

---8.25M

---6.56M

---13.78M

---12.60M

Basic earnings per share

---7.71

---19.73

---10.86

---15.78

---22.13

---17.87

---38.05

---36.47

Diluted earnings per share

---7.71

---19.73

---10.86

---15.78

---22.13

---17.87

---38.05

---36.47

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

